Zoetis ScourGuard 4KC Cattle Vaccine, Killed Virus, 100mL

ScourGuard^® 4KC has been demonstrated to be effective against diarrhea in calves caused by bovine rotavirus (serotypes G6 and G10), bovine coronavirus, Escherichia coli (E. coli) and Clostridium perfringens Type C when calves nurse vaccinated dams.

Indications

Vaccination of healthy, pregnant cows and heifers as an aid in preventing diarrhea in their calves caused by bovine rotavirus (serotypes G6 and G10), bovine coronavirus, enterotoxigenic strains of E. coli having the K99 pili adherence factor, and Cl. perfringens Type C.

Directions

General Directions: Vaccination of healthy, pregnant cows and heifers is recommended. Mix well. Aseptically administer 2 mL intramuscularly (IM) only. In accordance with Beef Quality Assurance guidelines, this product should be administered in the muscular region of the neck.

Primary Vaccination: Administer two IM doses approximately three weeks apart to pregnant cows, with the second dose given three to six weeks before calving.

Revaccination: Revaccination with a single dose three to six weeks before each subsequent calving is recommended. Good animal husbandry and herd-health management practices, including biosecurity, infectious disease control and annual revaccination should be employed.

SAFETY: The safety of ScourGuard^® 4KC in pregnant cows and heifers was demonstrated in three field safety studies conducted in three different geographic locations. No significant adverse events were observed in vaccinates following administration of ScourGuard 4KC.

PRECAUTIONS:

1. Store at 2° C to 7° C. Prolonged exposure to higher temperatures may adversely affect potency. Do not freeze.
2. Use entire contents when first opened.
3. Sterilized syringes and needles should be used to administer this vaccine.
4. Do not vaccinate within 21 days before slaughter.
5. Contains gentamicin and merthiolate as preservatives.
6. Transient temperature increases may occur following vaccination.
7. As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy.